A phase I trial of GEN 1 in patients with glioblastoma.
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2015
At a glance
- Drugs GEN 1 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2015 Planned initiation date changed from 1 Feb 2016 to 1 Jul 2015, as per Celsion media release.
- 09 Sep 2015 Planned initiation date changed from 1 Dec 2015 to 1 Feb 2016, as per Celsion media release.
- 06 Jan 2015 Celsion Corporation is still planning to initiate this trial, according to a company media release.